Fortress Biotech (FBIO) Current Deferred Revenue (2016 - 2023)
Fortress Biotech (FBIO) posted Current Deferred Revenue of $547,000 for Q1 2023, down 73.1% from $2.03 million a year earlier and down 24.9% from the prior quarter.
Powered by 
Analysis
Fortress Biotech (FBIO) Current Deferred Revenue (2016 - 2023) Analysis & Trends
At the end of FY2022, Fortress Biotech's Current Deferred Revenue came in at $728,000, down 72.1% from FY2021.
- Annual Current Deferred Revenue shows a five-year compound annual growth rate of -1.5% (FY2017 to FY2022).
- In prior years, Fortress Biotech's Current Deferred Revenue was $2.61 million in FY2021.
- The Q1 2023 figure stands as the lowest quarterly Current Deferred Revenue in data going back to Q3 2016.
- On a year-over-year basis, Current Deferred Revenue has declined in each of the last five quarters, with an average decline of 70.8% over the last five quarters.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $728,000 (Q4 2022), $1.09 million (Q3 2022) and $1.46 million (Q2 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Fortress Biotech | 73.28 Mn | -321.33 Mn | 12.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 547,000.00 |
| Dec 31, 2022 | 728,000.00 |
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 1.46 Mn |
| Mar 31, 2022 | 2.03 Mn |
| Dec 31, 2021 | 2.61 Mn |
| Sep 30, 2021 | 3.35 Mn |
| Jun 30, 2021 | 4.80 Mn |
| Mar 31, 2021 | 7.20 Mn |
| Jun 30, 2018 | 681,000.00 |
| Mar 31, 2018 | 733,000.00 |
| Dec 31, 2017 | 786,000.00 |
| Sep 30, 2017 | 838,000.00 |
| Jun 30, 2017 | 891,000.00 |
| Mar 31, 2017 | 943,000.00 |
| Dec 31, 2016 | 995,000.00 |
| Sep 30, 2016 | 1.01 Mn |
API Access
Fortress Biotech Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=FBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "FBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=FBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();